Inhibition of hyaluronan export reduces collagen degradation in interleukin-1 treated cartilage

Arthritis Research and Therapy

Volumn 10, Issue 1, 2008, Pages

  Deiters, Barthold ^a   Prehm, Peter ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; COLLAGEN; CYCLIC GMP; GELATINASE; HORSERADISH PEROXIDASE; HYALURONIC ACID; INTERLEUKIN 1ALPHA; MULTIDRUG RESISTANCE PROTEIN 5; PHOSPHODIESTERASE V INHIBITOR; PROTEOGLYCAN; TADALAFIL; VARDENAFIL; ZAPRINAST; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; INTERLEUKIN 1; MULTIDRUG RESISTANCE PROTEIN; PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTICULAR CARTILAGE; CATTLE; COLLAGEN DEGRADATION; COLLAGEN SYNTHESIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; DIFFUSION; ENZYME ACTIVATION; NONHUMAN; OSTEOARTHRITIS; PROTEIN SECRETION; PROTEIN SYNTHESIS INHIBITION; TISSUE CULTURE; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; IN VITRO STUDY; MALE; METABOLISM; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; BIOLOGICAL TRANSPORT; CARTILAGE, ARTICULAR; CATTLE; COLLAGEN; DIFFUSION; GELATINASES; HORSERADISH PEROXIDASE; HYALURONIC ACID; INDICATORS AND REAGENTS; INTERLEUKIN-1; MALE; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; PROTEINS; PROTEOGLYCANS;

EID: 39049115528     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar2357     Document Type: Article

References (50)

1. Prehm P Hyaluronate is synthesized at plasma membranes Biochem J 1984, 220:597-600. 1153665 6743290
2. Prehm P Synthesis of hyaluronate in differentiated teratocarcinoma cells. Mechanism of chain growth Biochem J 1983, 211:191-198. 1154343 6870820
3. Prehm P Synthesis of hyaluronate in differentiated teratocarcinoma cells. Characterization of the synthase Biochem J 1983, 211:181-189. 1154342 6409089
4. Prehm P Biosynthesis of hyaluronan: Direction of chain elongation Biochem J 2006, 398:469-473. 1559447 16719838 10.1042/BJ20060431
5. Tlapak-Simmons VL Kempner ES Baggenstoss BA Weigel PH The active streptococcal hyaluronan synthases (HASs) contain a single HAS monomer and multiple cardiolipin molecules J Biol Chem 1998, 273:26100-26109. 10.1074/jbc.273.40.26100 9748290
6. Pummill PE Kempner ES DeAngelis PL Functional molecular mass of a vertebrate hyaluronan synthase as determined by radiation inactivation analysis J Biol Chem 2001, 276:39832-39835. 10.1074/jbc.M105489200 11517224
7. Prehm P Schumacher U Inhibition of hyaluronan export from human fibroblasts by inhibitors of multidrug resistance transporters Biochem Pharmacol 2004, 68:1401-1410. 10.1016/j.bcp.2004.06.017 15345330
8. Schulz T Schumacher U Prehm P Hyaluronan export by the abc-transporter mrp5 and its modulation by intracellular cGMP J Biol Chem 2007, 282:20999-21004. 10.1074/jbc.M700915200 17540771
9. Prehm P Mechanism, localization, and inhibition of hyaluronate synthesis Articular cartilage biochemistry New York, NY: Raven Press Kuettner K 1986, 81-91.
10. Tang LH Buckwalter JA Rosenberg LC Effect of link protein concentration on articular cartilage proteoglycan aggregation J Orthop Res 1996, 14:334-339. 10.1002/jor.1100140225 8648515
11. Morales TI Hascall VC Correlated metabolism of proteoglycans and hyaluronic acid in bovine cartilage organ cultures J Biol Chem 1988, 263-3632. 3638 3346212
12. Maroudas A Palla G Gilav E Racemization of aspartic acid in human articular cartilage Connect Tissue Res 1992, 28:161-169. 10.3109/ 03008209209015033 1468204
13. Sugimoto K Iizawa T Harada H Yamada K Katsumata M Takahashi M Cartilage degradation independent of MMP/aggrecanases Osteoarthritis Cartilage 2004, 12:1006-1014. 10.1016/j.joca.2004.09.003 15564068
14. Arner EC Aggrecanase-mediated cartilage degradation Curr Opin Pharmacol 2002, 2:322-329. 10.1016/S1471-4892(02)00148-0 12020478
15. Smith GN Jr The role of collagenolytic matrix metalloproteinases in the loss of articular cartilage in osteoarthritis Front Biosci 2006, 11:3081-3095. 10.2741/2034 16720377
16. Salminen-Mankonen HJ Morko J Vuorio E Role of cathepsin K in normal joints and in the development of arthritis Curr Drug Targets 2007, 8:315-323. 10.2174/138945007779940188 17305509
17. Embry JJ Knudson W G1 domain of aggrecan cointernalizes with hyaluronan via a CD44-mediated mechanism in bovine articular chondrocytes Arthritis Rheum 2003, 48:3431-3441. 10.1002/art.11323 14673994
18. Hua Q Knudson CB Knudson W Internalization of hyaluronan by chondrocytes occurs via receptor-mediated endocytosis J Cell Sci 1993, 106:365-375. 7505784
19. D'Souza AL Masuda K Otten LM Nishida Y Knudson W Thonar EJ Differential effects of interleukin-1 on hyaluronan and proteoglycan metabolism in two compartments of the matrix formed by articular chondrocytes maintained in alginate Arch Biochem Biophys 2000, 374:59-65. 10.1006/ abbi.1999.1626 10640396
20. Sztrolovics R White RJ Roughley PJ Mort JS The mechanism of aggrecan release from cartilage differs with tissue origin and the agent used to stimulate catabolism Biochem J 2002, 362:465-472. 1222408 11853556 10.1042/0264-6021:3620465
21. Nishida Y D'Souza AL Thonar EJ Knudson W Stimulation of hyaluronan metabolism by interleukin-1alpha in human articular cartilage Arthritis Rheum 2000, 43:1315-1326. 10.1002/ 1529-0131(200006)43:6<1315::AID-ANR14>3.0.CO;2-# 10857790
22. Smith RL Degradative enzymes in osteoarthritis Front Biosci 1999, 4:D704-D712. 10525483
23. Poole AR Nelson F Dahlberg L Tchetina E Kobayashi M Yasuda T Laverty S Squires G Kojima T Wu W Billinghurst RC Proteolysis of the collagen fibril in osteoarthritis Biochem Soc Symp 2003, 70:115-123. 14587287
24. Bottomley KM Borkakoti N Bradshaw D Brown PA Broadhurst MJ Budd JM Elliott L Eyers P Hallam TJ Handa BK Hill CH James M Lahm HW Lawton G Merritt JE Nixon JS Röthlisberger U Whittle A Johnson WH Inhibition of bovine nasal cartilage degradation by selective matrix metalloproteinase inhibitors Biochem J 1997, 323:483-488. 1218345 9163342
25. Caputo CB Sygowski LA Wolanin DJ Patton SP Caccese RG Shaw A Roberts RA DiPasquale G Effect of synthetic metalloprotease inhibitors on cartilage autolysis in vitro J Pharmacol Exp Ther 1987, 240:460-465. 3543299
26. Cawston T Plumpton T Curry V Ellis A Powell L Role of TIMP and MMP inhibition in preventing connective tissue breakdown Ann N Y Acad Sci 1994, 732:75-83. 10.1111/j.1749-6632.1994.tb24726.x 7978853
27. Seed MP Thomson TA Gardner CR Investigation of the role of metalloproteinases in recombinant human interleukin-1 beta-induced degradation of rat femoral head cartilage Drugs Exp Clin Res 1991, 17:355-361. 1794302
28. Greenwald RA Thirty-six years in the clinic without an MMP inhibitor. What hath collagenase wrought? Ann N Y Acad Sci 1999, 878:413-419. 10.1111/j.1749-6632.1999.tb07699.x 10415745
29. Elliott S Cawston T The clinical potential of matrix metalloproteinase inhibitors in the rheumatic disorders Drugs Aging 2001, 18:87-99. 10.2165/00002512-200118020-00002 11346130
30. Prehm P Inhibitors of hyaluronan export prevent proteoglycan loss from osteoarthritic cartilage J Rheumatol 2005, 32:690-696. 15801027
31. Andric SA Kostic TS Stojilkovic SS Contribution of multidrug resistance protein MRP5 in control of cGMP intracellular signaling in anterior pituitary cells Endocrinology 2006, 147:3435-3445. 10.1210/en.2006-0091 16614078
32. Kulkarni SK Patil CS Phosphodiesterase 5 enzyme and its inhibitors: update on pharmacological and therapeutical aspects Methods Find Exp Clin Pharmacol 2004, 26:789-799. 10.1358/mf.2004.26.10.872561 15672122
33. Pratt S Shepard RL Kandasamy RA Johnston PA Perry W III Dantzig AH The multidrug resistance protein 5 (ABCC5) confers resistance to 5-fluorouracil and transports its monophosphorylated metabolites Mol Cancer Ther 2005, 4:855-863. 10.1158/1535-7163.MCT-04-0291 15897250
34. O'Brien J Wilson I Orton T Pognan F Investigation of the alamar blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity Eur J Biochem 2000, 267:5421-5426. 10.1046/ j.1432-1327.2000.01606.x 10951200
35. Bjornsson S Simultaneous preparation and quantitation of proteoglycans by precipitation with alcian blue Anal Biochem 1993, 210:282-291. 10.1006/abio.1993.1197 8512063
36. Terry DE Chopra RK Ovenden J Anastassiades TP Differential use of alcian blue and toluidine blue dyes for the quantification and isolation of anionic glycoconjugates from cell cultures: Application to proteoglycans and a high-molecular-weight glycoprotein synthesized by articular chondrocytes Anal Biochem 2000, 285:211-219. 10.1006/abio.2000.4761 11017704
37. Kosaki R Watanabe K Yamaguchi Y Overproduction of hyaluronan by expression of the hyaluronan synthase Has2 enhances anchorage-independent growth and tumorigenicity Cancer Res 1999, 59:1141-1145. 10070975
38. Sasaki K Hattori T Fujisawa T Takahashi K Inoue H Takigawa M Nitric oxide mediates interleukin-1-induced gene expression of matrix metalloproteinases and basic fibroblast growth factor in cultured rabbit articular chondrocytes J Biochem (Tokyo) 1998, 123:431-439.
39. Geng Y Zhou L Thompson WJ Lotz M Cyclic GMP and cGMP-binding phosphodiesterase are required for interleukin-1-induced nitric oxide synthesis in human articular chondrocytes J Biol Chem 1998, 273:27484-27491. 10.1074/jbc.273.42.27484 9765278
40. Turko IV Francis SH Corbin JD Potential roles of conserved amino acids in the catalytic domain of the cGMP-binding cGMP-specific phosphodiesterase J Biol Chem 1998, 273:6460-6466. 10.1074/ jbc.273.11.6460 9497379
41. Blount MA Zoraghi R Ke H Bessay EP Corbin JD Francis SH A 46-amino acid segment in phosphodiesterase-5 GAF-B domain provides for high vardenafil potency over sildenafil and tadalafil and is involved in phosphodiesterase-5 dimerization Mol Pharmacol 2006, 70:1822-1831. 10.1124/mol.106.028688 16926278
42. Sundkvist E Jaeger R Sager G Pharmacological characterization of the ATP-dependent low K(m) guanosine 3′,5′-cyclic monophosphate (cGMP) transporter in human erythrocytes Biochem Pharmacol 2002, 63:945-949. 10.1016/S0006-2952(01)00940-6 11911846
43. Borst P de WC van de WK Multidrug resistance-associated proteins 3, 4, and 5 Pflugers Arch 2006, 453:661-673. 10.1007/s00424-006-0054-9 16586096
44. Kozaci LD Buttle DJ Hollander AP Degradation of type II collagen, but not proteoglycan, correlates with matrix metalloproteinase activity in cartilage explant cultures Arthritis Rheum 1997, 40:164-174. 10.1002/ art.1780400121 9008612
45. Billinghurst RC Wu W Ionescu M Reiner A Dahlberg L Chen J van Wart H Poole AR Comparison of the degradation of type II collagen and proteoglycan in nasal and articular cartilages induced by interleukin-1 and the selective inhibition of type II collagen cleavage by collagenase Arthritis Rheum 2000, 43:664-672. 10.1002/ 1529-0131(200003)43:3<664::AID-ANR24>3.0.CO;2-D 10728761
46. Bayliss MT Howat S Davidson C Dudhia J The organization of aggrecan in human articular cartilage. Evidence for age-related changes in the rate of aggregation of newly synthesized molecules J Biol Chem 2000, 275:6321-6327. 10.1074/jbc.275.9.6321 10692431
47. Aigner T Soeder S Haag J IL-1beta and BMPs - interactive players of cartilage matrix degradation and regeneration Eur Cell Mater 2006, 12:49-56. 17068722
48. Maroudas A Biophysical chemistry of cartilaginous tissues with special reference to solute and fluid transport Biorheology 1975, 12:233-248. 1106795
49. Maroudas A Scheiderman R Popper O The role of water, proteoglycan, and collagen in solute transport in cartilage Articular Cartilage and Osteoarthritis New York, NY: Raven Press Kuettner K, Schleyerbach R, Peyron JG, Hascall VC 1992, 355-371.
50. Pratta MA Yao W Decicco C Tortorella MD Liu RQ Copeland RA Magolda R Newton RC Trzaskos JM Arner EC Aggrecan protects cartilage collagen from proteolytic cleavage J Biol Chem 2003, 278:45539-45545. 10.1074/ jbc.M303737200 12890681